No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Qube Research
$35.4M
added
D.E. Shaw
$33.4M
added
Sells/Trims (1)
Marshall Wace
$84.9M
trimmed
Sells (1)
No tracked top-trader positions in VSNT as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.39 expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $1.49 / $1.39Alpha Vantage | +7.19% beat | $1.64B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | May 14, 2026 | $2.02 / $2.16Alpha Vantage | -6.48% miss | $1.69B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Mar 3, 2026 | $1.25 / $0.50Alpha Vantage | +149.70% beat | $6.69B No estimateYear ended Dec 31, 2025 · SEC filing | Unavailable |
| Sep 30, 2025 | Dec 3, 2025 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2026 | Unavailable | - | $1.71B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | May 14, 2026 | Unavailable | - | $1.71B No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
Fairly priced and profitable.
Valuation
Quality
Growth
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace